IP Library Granted Patent US 10,654,901
Granted Patent B2
US 10,654,901 · App. 15/569,022 · Granted May 19, 2020

Microorganisms with increased photosynthetic capacity

Inventors: James Roberts (Seattle, WA); Damian Carrieri (Seattle, WA); Mark Heinnickel (Seattle, WA)
Assignees: Lumen Bioscience, Inc.; Reliance Holding USA, Inc.
C07K14/195C12N9/22C12N15/11C12N15/90C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,654,901
App. No.
15/569,022
Granted
May 19, 2020
Kind
B2
Abstract

Microorganisms with increased photosynthetic capacity are described. Increased photosynthetic capacity is achieved by down-regulating activity of the RpaB pathway. The microorganisms include Cyanobacteria, including genetically-modified Cyanobacteria.

Claims (8)

1. A genetically-modified Cyanobacterium comprising an exogenous nucleotide sequence comprising SEQ ID NO: 23 that expresses an N-terminal fragment of RpaB polypeptide comprising the amino acid sequence of SEQ ID NO: 2, and wherein the N-terminal fragment does not comprise a DNA binding domain or a functional DNA binding domain, under the control of a promoter that results in down-regulated RpaB pathway activity in the genetically-modified Cyanobacterium as compared to a Cyanobacterium of the same species without the exogenous nucleotide sequence.

2. The genetically-modified Cyanobacterium of claim 1 wherein the promoter is

(a) an inducible promoter; or

(b) endogenous to the genome of the genetically-modified Cyanobacterium.

3. The genetically-modified Cyanobacterium of claim 1 wherein the genetically-modified Cyanobacterium is a Cyanobacterium selected from Synechococcus elongatus, Arthrospira maxima, Arthrospira platensis , and Cyanobacterium aponinum.

4. The genetically-modified Cyanobacterium of claim 1 wherein the genetically-modified Cyanobacterium has increased

(a) photosynthetic capacity as compared to a Cyanobacterium of the same species without the exogenous nucleotide sequence; and/or

(b) photosynthetic biomass accumulation from photoautotrophic growth as compared to a Cyanobacterium of the same species without the exogenous nucleotide sequence.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2020
From: ROBERTS, JAMES; CARRIERI, DAMIAN; HEINNICKEL, MARK
To: MATRIX GENETICS, LLC
Reel/Frame 051469/0066 →
Continuity (2)
Provisional Application 62152506 · Apr 24, 2015
Related Publication 20180134755A1 · May 17, 2018
Cited By (3)
US 12,252,513 US 12,447,202 US 12,503,682